Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Enhanced Thermogenesis in Triple-Negative Breast Cancer Is Associated with Pro-Tumor Immune Microenvironment

Cancers(2021)10.3390/cancers13112559Source: DataRank Database

Enhanced Thermogenesis in Triple-Negative Breast Cancer Is Associated with Pro-Tumor Immune Microenvironment is a research paper published in Cancers (2021). On theSindex it has a DataRank of 0. It has been cited 37 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access37 citations

Download PDF

Cite:

Linked data & code

geo nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (15 grants)OA: goldTopics (11)Linked Datasets (2)DataCite Reuse (2)IDs (PubMed, PMC)Annotations (3)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Masanori Oshi ORCID,Vijayashree Murthy ORCID,Elizabeth A. Repasky ORCID,Kazuaki Takabe ORCID,Shipra Gandhi ORCID

Live enrichment

PubMed:34071012 PMC:PMC8197168

NIH HHS

Grant: R01CA160688

NIH HHS

Grant: R01CA205246

NIH HHS

Grant: R37CA248018

National Institutes of Health

Grant: R01CA250412

National Institutes of Health

Grant: UL1TR001412

U.S. Department of Defense

Grant: W81XWH-19-1-0674

National Cancer Institute

Grant: P30CA016056

NCATS NIH HHS

Grant: KL2 TR001413

National Institutes of Health

Grant: 5P30CA016056-40

Roswell Park Cancer Institute Cancer Center Support Grant

National Institutes of Health

Grant: 5KL2TR001413-03

Buffalo Clinical and Translational Research Center

National Institutes of Health

Grant: 3UL1TR001412-08S3

Buffalo Clinical and Translational Research Center

National Institutes of Health

Grant: 5R37CA248018-04

Leveraging the GTP Biosynthetic Pathway for Anti-Tumor Therapies

National Institutes of Health

Grant: 5R01CA205246-03

Understanding how adrenergic signaling influences immune contexture of tumors and the efficacy of checkpoint inhibitors

National Institutes of Health

Grant: 5R01CA160688-03

Sphingosine-1-phosphate in breast cancer progression and lymphangiogenesis

National Institutes of Health

Grant: 5R01CA250412-02

Impact of Circulating Myeloid Cell Clusters on Anti-Tumor Immunity

goldLicense: CC BY

Europe_PMChttps://europepmc.org/articles/PMC8197168

Europe_PMChttps://europepmc.org/articles/PMC8197168?pdf=render

https://doi.org/10.3390/cancers13112559

https://www.mdpi.com/2072-6694/13/11/2559/pdf

https://pubmed.ncbi.nlm.nih.gov/34071012

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

ThermogenesisCold stressTumor MicroenvironmentTriple-negative Breast CancerTcgaMetabricGse96058Article

Sustainable Development Goals

SDG 2: 2. Zero hungerSDG 3: 3. Good health

Additional file 1 of Dual depletion of myeloid-derived suppressor cells and tumor cells with self-assembled gemcitabine-celecoxib nano-twin drug for cancer chemoimmunotherapy

10.6084/m9.figshare.25996806.v1figshare

Additional file 1 of Dual depletion of myeloid-derived suppressor cells and tumor cells with self-assembled gemcitabine-celecoxib nano-twin drug for cancer chemoimmunotherapy

10.6084/m9.figshare.25996806figshare